Articles Tập 67 Số CĐ13-HNKH Bệnh viện 19-8 10/09/2026

INITIAL OUTCOMES OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) VIA TRANSURETHRAL ENDOSCOPIC APPROACH FOR BENIGN PROSTATE HYPERPLASIA AT 19-8 HOSPITAL

Thành Nguyễn Trần, Thắng Chu Van, Quang Nguyễn, Hà Đinh Ngọc, Hiệu Nguyễn Huy, Anh Nguyễn Thế
DOI: 10.52163/yhc.v67iCD13.6395
0 Views
0 Downloads
Keywords
Benign prostatic hyperplasia, Holmium laser enucleation of the prostate, large benign prostate.
Abstract

Objective:
To evaluate patient characteristics, perioperative parameters, changes in voiding function, urodynamic outcomes, and quality of life, as well as perioperative complications in patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) at 19-8 Hospital.

Materials and Methods:

A total of 25 patients diagnosed with benign prostatic hyperplasia (BPH) with prostate volume >80 gram were included in this descriptive case series. All patients underwent clinical evaluation, International Prostate Symptom Score (IPSS) assessment, informed consent was obtained prior to surgery. The following parameters were recorded: PSA, urinary flow rate, prostate volume, operative time, intraoperative blood loss, need for blood transfusion, catheterization time, length of hospital stay, and perioperative complications.

Results:

From November 2024 to March 2026, 25 HoLEP procedures were performed. The mean age was 70,1 ± 6,3 years. The mean prostate volume was 92,5 ± 7,6 g (80–140). The mean operative time was 70 ± 6,6 minutes (60–120). The mean catheterization time was 1,88 ± 0,42 days. International Prostate Symptom Score (IPSS) significantly decreased from 25 preoperatively to 11 at 1 month and 9,2 at 6 months (p < 0.001). The maximum urinary flow rate (Qmax) improved from 6,8 to 19,8 mL/s at 6 months (p < 0.001). Post-void residual urine (PVR) decreased from 190,5 to 18,2 mL at 6 months (p < 0.001). Quality of Life (QoL) scores improved from 4,0 to 1,5 at 6 months (p < 0.001).

Conclusions:

The initial outcomes of HoLEP at 19-8 Hospital, Ministry of Public Security, demonstrate favorable results. HoLEP is a safe and effective surgical option for the treatment of large-volume benign prostatic hyperplasia.

Keywords:

References
[1]
(1) Carbone A, Fuschi A, Al Rawashdah SF, Al Salhi Y, Velotti G, Ripoli A, Autieri D, Palleschi G, Pastore AL. (2016). Management of lower urinary tract symptoms associated with benign prostatic hyperplasia in elderly patients with a new diagnostic, therapeutic and care pathway. International Journal of Clinical Practice. 70:734-743. DOI: 10.1111/ijcp.12849. Google Scholar
[2]
(2) European Association of Urology. (2026). EAU guidelines on non-neurogenic male LUTS. Available from: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2026-1.pdf [Accessed 25 April 2026]. Google Scholar
[3]
(3) ElShal AM, Soltan M, El-Tabey NA, Laymon M, Nabeeh A. (2020). Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU International. 126:731-738. DOI: 10.1111/bju.15161. Google Scholar
[4]
(4) Thành ĐT, et al. (2024). Kết quả phẫu thuật bóc nhân phì đại lành tính tuyến tiền liệt bằng holmium laser qua đường niệu đạo tại Bệnh viện Hữu nghị Việt Đức giai đoạn 2022-2024. Tạp chí Y học Việt Nam. Available from: https://tapchiyhocvietnam.vn/index.php/vmj/article/view/16347/13981 [Accessed 25 April 2026]. Google Scholar
[5]
(5) Ortner G, Pang KH, Yuan Y, et al. (2023). Peri- and post-operative outcomes, complications, and functional results amongst different modifications of endoscopic enucleation of the prostate (EEP): a systematic review and meta-analysis. World Journal of Urology. 41:969-980. DOI: 10.1007/s00345-023-04308-z. Google Scholar
[6]
(6) Ou R, You M, Tang P, Deng X, Yang W, Xiong S, et al. (2010). A randomized trial of transvesical prostatectomy versus transurethral resection of the prostate for benign prostatic hyperplasia with prostate volume greater than 80 mL. Urology. 76(4):958-961. Google Scholar
[7]
(7) Bayraktar N, Başeskioğlu AB. (2024). Holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP) in elderly patients: insights into recovery, complications, and risk factors. Cureus. 16(12):e76384. DOI: 10.7759/cureus.76384. Google Scholar
[8]
(8) Zhang Y, Yuan P, Ma D, Gao X, Wei C, Liu Z, Li R, Wang S, Liu J, Liu X. (2019). Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. DOI: 10.1038/s41391-019-0135-4 Google Scholar
[9]
(9) Gravas S, et al. (2022). EAU guidelines on management of non-neurogenic male LUTS, including BPH. European Urology. 82(2):213-225. Google Scholar
[10]
(10) Tuấn HX, Châu NN, Bách TN. (2021). Đánh giá sớm kết quả bóc nhân tuyến tiền liệt bằng holmium laser trong điều trị bướu lành tuyến tiền liệt thể tích lớn tại Bệnh viện Bình Dân. Tạp chí Y học Việt Nam. Available from: https://tapchiyhocvietnam.vn/index.php/vmj/article/view. Google Scholar